Haoxi Health Technology Ltd.
13F holders, Q1 2024 (March 31)2holders
$6.06avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Haoxi Health Technology Ltd. in their 13F filings. The largest holders were UBS Group AG ($497) and JPMorgan Chase & Co. ($18).
- Company
- Haoxi Health Technology Ltd.
- CUSIP
- G4290F100
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $515 |
| Exits | 0 | $0 |
Ownership 2 holders
| UBS Group AG | 0.00% | New | 82 | $497 |
| JPMorgan Chase & Co. | 0.00% | New | 3 | $18 |
"% of holder's portfolio" is HAOXI HEALTH TECHNOLOGY LTD's weight in each manager's 13F, not the share of Haoxi Health Technology Ltd. the manager owns.